SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria

Background: Idiopathic hypercalciuria (IHC) is associated with reduced bone mineral density (BMD) and higher risk of osteoporotic fractures. Denosumab is a RANK-ligand inhibitor that prevents osteoporosis-related fractures. No previous published studies have specifically evaluated denosumab treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Winston S, Chu, James W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Bone and Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207871/
http://dx.doi.org/10.1210/jendso/bvaa046.1275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207871/
http://dx.doi.org/10.1210/jendso/bvaa046.1275

Ejemplares similares